ENSC · Ensysce Biosciences, Inc.
$0.39
0.00 (-1.17%)
At close · Sep 1
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. While the Company believes in the viability of its strategy to ultimately realize revenues and in its ability to raise additional funds, management cannot be certain that additional funding will be available on acceptable terms, or at all. The Company's ability to continue as a going concern is dependent upon its ability to obtain adequate financing and achieve profitable operations. As a result, these plans do not alleviate substantial doubt about the Company's ability to continue as a going concern for a period of 12 months following the date these consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.45M
Shares
19.46M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-27 | 39,973 | 705,903 | 745,876 | 65.3% |
| 2026-07-20 | 65,913 | 806,750 | 872,663 | 69.5% |
| 2026-07-13 | 152,411 | 12,554,458 | 12,706,869 | 60.1% |
| 2026-07-06 | 47,758 | 1,287,415 | 1,335,173 | 64.8% |
| 2026-06-29 | 49,500 | 1,103,518 | 1,153,018 | 66.3% |
| 2026-06-22 | 145,916 | 4,112,253 | 4,258,169 | 72.5% |
| 2026-06-15 | 198,345 | 3,733,237 | 3,931,582 | 73.7% |
| 2026-06-08 | 232,557 | 3,697,707 | 3,930,264 | 73.3% |
| 2026-06-01 | 700,230 | 5,136,525 | 5,836,755 | 72.2% |
| 2026-05-25 | 119,184 | 1,657,137 | 1,776,321 | 73.3% |
| 2026-05-18 | 362,275 | 3,500,888 | 3,863,163 | 70.8% |
| 2026-05-11 | 1,735,274 | 39,132,328 | 40,867,602 | 41.9% |
| 2026-05-04 | 53,694 | 617,074 | 670,768 | 64.6% |
| 2026-04-27 | 89,099 | 893,207 | 982,306 | 66.4% |
| 2026-04-20 | 55,822 | 788,708 | 844,530 | 66.3% |
| 2026-04-13 | 74,300 | 874,852 | 949,152 | 65.7% |
| 2026-04-06 | 90,177 | 826,178 | 916,355 | 65.1% |
| 2026-03-30 | 29,386 | 738,099 | 767,485 | 71.8% |
| 2026-03-23 | 47,741 | 912,747 | 960,488 | 73.2% |
| 2026-03-16 | 328,403 | 6,348,852 | 6,677,255 | 64.3% |
| 2026-03-09 | 106,426 | 1,328,905 | 1,435,331 | 64.3% |
| 2026-03-02 | 848,164 | 9,725,027 | 10,573,191 | 53.7% |
| 2026-02-23 | 7,985,226 | 134,563,317 | 142,548,543 | 49.8% |
| 2026-02-16 | 1,433,916 | 20,189,084 | 21,623,000 | 57.9% |
| 2026-02-09 | 344,866 | 4,369,942 | 4,714,808 | 41.5% |
| 2026-02-02 | 43,994 | 673,235 | 717,229 | 64.7% |
| 2026-01-26 | 29,481 | 307,799 | 337,280 | 63.0% |
| 2026-01-19 | 28,396 | 288,065 | 316,461 | 62.6% |
| 2026-01-12 | 28,281 | 329,985 | 358,266 | 66.3% |
| 2026-01-05 | 23,191 | 342,403 | 365,594 | 62.5% |
| 2025-12-29 | 22,135 | 475,407 | 497,542 | 67.6% |
| 2025-12-22 | 14,691 | 156,475 | 171,166 | 65.4% |
| 2025-12-15 | 40,885 | 484,491 | 525,376 | 66.3% |
| 2025-12-08 | 110,376 | 3,311,421 | 3,421,797 | 48.5% |
| 2025-12-01 | 10,727 | 154,337 | 165,064 | 56.9% |
| 2025-11-24 | 12,845 | 122,897 | 135,742 | 60.6% |
| 2025-11-17 | 30,835 | 368,066 | 398,901 | 50.0% |
| 2025-11-10 | 27,419 | 139,014 | 166,433 | 52.3% |
| 2025-11-03 | 15,590 | 111,794 | 127,384 | 48.1% |
| 2025-10-27 | 12,836 | 100,834 | 113,670 | 56.2% |
| 2025-10-20 | 48,312 | 325,627 | 373,939 | 58.7% |
| 2025-10-13 | 98,779 | 460,951 | 559,730 | 70.7% |
| 2025-10-06 | 34,002 | 703,457 | 737,459 | 48.9% |
| 2025-09-29 | 25,981 | 558,275 | 584,256 | 62.8% |
| 2025-09-22 | 13,548 | 305,842 | 319,390 | 68.1% |
| 2025-09-15 | 15,045 | 145,278 | 160,323 | 51.9% |
| 2025-09-08 | 10,684 | 153,489 | 164,173 | 51.5% |
Showing 1–47 of 47 weeks
Key facts
CIK
1716947
CUSIP
293602504
13F (30d)
17 filings
17 filers
Visit website
Investor relations